TY  - JOUR
AU  - Al-Hamed, Faez Saleh
AU  - Kouniaris, Stamatis
AU  - Tamimi, Iskandar
AU  - Lordkipanidze, Marie
AU  - Madathil, Sreenath Arekunnath
AU  - Kezouh, Abbas
AU  - Karp, Igor
AU  - Nicolau, Belinda
AU  - Tamimi, Faleh
PY  - 2021
DO  - 10.1002/trc2.12184
UR  - https://hdl.handle.net/10668/24350
T2  - Alzheimers & dementia-translational research & clinical interventions
AB  - Introduction Acetylcholinesterase inhibitors (AChEIs) are commonly used to treat mild to moderate cases of Alzheimer disease (AD). To the best of our knowledge, there has been no study estimating the risk of bleeding and cardiovascular events in...
LA  - en
PB  - Wiley
KW  - acetylcholinesterase inhibitors
KW  - aging
KW  - Alzheimer's disease
KW  - bleeding
KW  - cardiovascular disease
KW  - stroke
KW  - Cholinesterase-inhibitors
KW  - Myocardial-infarction
KW  - Blood-pressure
KW  - Disease
KW  - Dementia
KW  - Validity
KW  - Stroke
KW  - Adults
TI  - Acetylcholinesterase inhibitors and risk of bleeding and acute ischemic events in non-hypertensive Alzheimer's patients
TY  - research article
VL  - 7
ER  -